Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease
Kidney International · 2024-06 · 105 (6) · 1212-1220
DOI: 10.1016/j.kint.2024.02.020 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Kidney International, 2024-06. Verfasst von Tobias T Pieters und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Renal Insufficiency, Chronic, Disease Models, Animal. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Accurate assessment of the glomerular filtration rate (GFR) is crucial for researching kidney disease in rats. Although validation of methods that assess GFR is crucial, large-scale comparisons between different methods are lacking. Both transcutaneous GFR (tGFR) and a newly developed estimated GFR (eGFR) equation by our group provide a low-invasive approach enabling repeated measurements. The tGFR is a single bolus method using FITC-labeled sinistrin to measure GFR based on half-life of the transcutaneous signal, whilst the eGFR is based on urinary sinistrin clearance. Here, we retrospectively compared tGFR, using both 1- and 3- compartment models (tGFR_1c and tGFR_3c, respectively) to the eGFR in a historic cohort of 43 healthy male rats and 84 male rats with various models of chronic kidney disease. The eGFR was on average considerably lower than tGFR-1c and tGFR-3c (mean differences 855 and 216 μL/min, respectively) and only 20 and 47% of measurements were within 30% of each other, respectively. The relative difference between eGFR and tGFR was highest in rats with the lowest GFR. Possible explanations for the divergence are problems inherent to tGFR, such as technical issues with signal measurement, description of the signal kinetics, and translation of half-life to tGFR, which depends on distribution volume. The unknown impact of isoflurane anesthesia used in determining mGFR remains a limiting factor. Thus, our study shows that there is a severe disagreement between GFR measured by tGFR and eGFR, stressing the need for more rigorous validation of the tGFR and possible adjustments to the underlying technique.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands.
- Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Medicine, University Hospital Mannheim, University of Heidelberg, Mannheim, Germany.
- Department of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, The Netherlands. Electronic address: J.A.Joles@umcutrecht.nl.
Zitieren
APA
Pieters, T. T., Besseling, P. J., Bovée, D. M., Rookmaaker, M. B., Verhaar, M. C., Yard, B., Hoorn, E. J., & Joles, J. A. (2024). Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease. Kidney International, 105(6), 1212-1220. https://doi.org/10.1016/j.kint.2024.02.020
Vancouver
Pieters TT, Besseling PJ, Bovée DM, Rookmaaker MB, Verhaar MC, Yard B, et al. Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease. Kidney International. 2024;105(6):1212-1220. doi:10.1016/j.kint.2024.02.020
BibTeX
@article{Pieters2024,
author = {Pieters, Tobias T and Besseling, Paul J and Bovée, Dominique M and Rookmaaker, Maarten B and Verhaar, Marianne C and Yard, Benito and Hoorn, Ewout J and Joles, Jaap A},
title = {Discrepancies between transcutaneous and estimated glomerular filtration rates in rats with chronic kidney disease},
journal = {Kidney International},
year = {2024},
volume = {105},
number = {6},
pages = {1212--1220},
doi = {10.1016/j.kint.2024.02.020}
}
EUVIMED